EMA Regulatory Science Strategy Mid-point Report Published EMA Regulatory Science Strategy Mid-point Report Published The EMA has published a report summarising the mid-term achievements... EMA Regulatory Science Strategy Mid-point Report Published
EMA ISG Meeting Presentations – March 2023 EMA ISG Meeting Presentations – March 2023 EMA has published the presentations from the last Industry Standing Group (ISG) meeting... EMA ISG Meeting Presentations – March 2023
MHRA Consultation Response – Proposals for Legislative Changes for Clinical Trials MHRA Consultation Response – Proposals for Legislative Changes for Clinical Trials In January 2022 MHRA launched a consultation on a... MHRA Consultation Response – Proposals for Legislative Changes for Clinical Trials
MHRA Publishes Marketing Authorisations Granted 1 – 14 March 2023 MHRA Publishes Marketing Authorisations Granted 1 – 14 March 2023 MHRA granted four OTC licences during 1-14 March 2023. Details... MHRA Publishes Marketing Authorisations Granted 1 – 14 March 2023
MHRA Reclassifies Cialis Together Tablets to a Pharmacy Medicine MHRA Reclassifies Cialis Together Tablets to a Pharmacy Medicine The Medicines and Healthcare products Regulatory Agency (MHRA) has reclassified Cialis... MHRA Reclassifies Cialis Together Tablets to a Pharmacy Medicine
MHRA Drug Safety Update – Pholcodine MHRA Drug Safety Update – Pholcodine Following a review by the MHRA, together with advice from CHM, the UK regulator... MHRA Drug Safety Update – Pholcodine
MHRA Good Manufacturing and Distribution Practice Symposia 2023 Vestibulum id ligula porta felis euismod semper. Aenean lacinia bibendum nulla sed consectetur. Lorem ipsum dolor sit amet, consectetur adipiscing... MHRA Good Manufacturing and Distribution Practice Symposia 2023
AESGP Webinar – Water legislation in Europe and how does this affect the pharma industry? AESGP Webinar – ‘Water legislation in Europe and how does this affect the pharma industry?’ AESGP is hosting a members-only... AESGP Webinar – Water legislation in Europe and how does this affect the pharma industry?
MHRA – Patient Involvement Strategy: One Year On MHRA – Patient Involvement Strategy: One Year On MHRA has published a corporate report, ‘Patient Involvement Strategy: One Year On’... MHRA – Patient Involvement Strategy: One Year On
HMA/EMA Multi-stakeholder Workshop on Shortages HMA/EMA Multi-stakeholder Workshop on Shortages The European Medicines Agency (EMA) has published the presentations from the HMA (Heads... HMA/EMA Multi-stakeholder Workshop on Shortages
MHRA Publishes Marketing Authorisations Granted in 15 – 28 February 2023 MHRA Publishes Marketing Authorisations Granted in 15 – 28 February 2023 MHRA granted three OTC licences during 15 – 28... MHRA Publishes Marketing Authorisations Granted in 15 – 28 February 2023
EMA Webinar Week on SPOR and XEVMPD EMA Webinar Week on SPOR and XEVMPD EMA’s Regulatory Data Management Service is organising a full week of webinars during... EMA Webinar Week on SPOR and XEVMPD